Patent Applications published on Sep 5, 2024 - page 3

#601 ✅ Patent 12,303,493 granted on 2025-05-20
US20240293374A1
Human necessities

Anticancer compositions

#602 ✅ Patent 12,329,745 granted on 2025-06-17
US20240293375A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING GLUCOCORTICOID EXCESS

#603 ✅ Patent 12,343,334 granted on 2025-07-01
US20240293376A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING SEVERE CONSTIPATION

#604
US20240293377A1
Human necessities

COMPOSITIONS AND METHODS FOR INHIBITING CARP-1 BINDING TO NEMO

#605
US20240293378A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING GORLIN SYNDROME

#606
US20240293379A1
Human necessities

THERAPEUTIC AGENT FOR CANCER OF PATIENT WITH DECREASE IN RB1 FUNCTION USING MYT1 INHIBITOR AND CHEMOTHERAPEUTIC AGENT IN COMBINATION, AND TREATMENT METHOD THEREOF

#607
US20240293380A1
Human necessities

PROTEASE INHIBITORS AND METHODS OF USE

#608
US20240293381A1
Human necessities

Therapeutic Compounds

#609
US20240293382A1
Human necessities

MODIFIED RELEASE PHARMACEUTICAL FORMULATIONS COMPRISING DEFERIPRONE

#610
US20240293383A1
Human necessities

SUBSTITUTED DIAZASPIROALKANES AS ANDROGEN RECEPTOR MODULATORS

#611
US20240293384A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATMENT OF COVID-19

#612
US20240293385A1
Human necessities

COMBINATION THERAPY FOR TREATMENT OF LIVER DISEASES

#613
US20240293386A1
Human necessities

NOVEL COMPOUND AS PROTEIN KINASE INHIBITOR

#614
US20240293387A1
Human necessities

Methods of Treating Fabry Disease in Pediatric Patients

#615
US20240293388A1
Human necessities

New Centrally-Active Ghrelin Agonist and Medical Uses Thereof

#616
US20240293389A1
Human necessities

METHOD OF TREATING COGNITIVE DEFICITS ASSOCIATED WITH SCHIZOPHRENIA

#617 ✅ Patent 12,194,034 granted on 2025-01-14
US20240293390A1
Human necessities

Neutrophil exocytosis inhibitors

#618
US20240293391A1
Human necessities

ISOQUINOLINE AND PYRIDINE BASED CXCR4 ANTAGONISTS

#619
US20240293392A1
Human necessities

INHIBITOR COMPOUNDS

#620 ✅ Patent 12,343,338 granted on 2025-07-01
US20240293393A1
Human necessities

RAMIPRIL SOLUTION FOR ORAL DOSAGE

#621 ✅ Patent 12,194,035 granted on 2025-01-14
US20240293394A1
Human necessities

Methods for treating antipsychotic-induced weight gain

#622
US20240293395A1
Human necessities

NALTREXONE FOR IMPROVING THE EFFECTIVENESS OF 5-HT RECEPTOR SUBTYPE 2A, 2B or 2C AGONISTS

#623
US20240293396A1
Human necessities

READY-TO-ADMINISTER HYDROMORPHONE FORMULATIONS

#624
US20240293397A1
Human necessities

THERAPEUTIC USES OF 1-[2-(2,4-DIMETHYL-PHENYLSULFANYL)PHENYL]PIPERAZINE

#625
US20240293398A1
Human necessities

Defining RNA-Small Molecule Affinity Landscapes Enables Design of a Small Molecule Inhibitor...

#626
US20240293399A1
Human necessities

GASTRO-RESISTANT HIGH-STRENGTH FORMULATION CONTAINING POSACONAZOLE

#627
US20240293400A1
Human necessities

NOVEL AZAINDOLE DERIVATIVES AS ANTIVIRAL AGENTS

#628
US20240293401A1
Human necessities

COMBINATION THERAPY WITH AN LXR AGONIST AND AN INHIBITOR COMPOUND

#629
US20240293402A1
Human necessities

FORMULATION CONTAINING DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE (as amended)

#630
US20240293403A1
Human necessities

Treatment of Symptoms Associated with Myeloproliferative Neoplasms

#631
US20240293404A1
Human necessities

SALT AND CRYSTAL FORMS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR

#632
US20240293405A1
Human necessities

(1H-PYRROLO[2,3-B]PYRIDIN-1-YL)PYRIMIDIN-2-YL-AMINO-PHENYL-ACRYLAMIDE INHIBITORS OF EGFR FOR USE IN THE TREATMENT OF BRAIN TUMORS

#633
US20240293406A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING MYELOFIBROSIS

#634
US20240293407A1
Human necessities

METHODS OF TREATING CANCERS

#635
US20240293408A1
Human necessities

METHODS OF TREATING AND PREVENTING GRAFT VERSUS HOST DISEASE

#636
US20240293409A1
Human necessities

METHODS OF TREATING AND PREVENTING ALLOANTIBODY DRIVEN CHRONIC GRAFT VERSUS HOST DISEASE

#637
US20240293410A1
Human necessities

COMPOSITIONS FOR TREATING SPINAL MUSCULAR ATROPHY

#638
US20240293411A1
Human necessities

COMBINATION THERAPY COMPRISING JAK PATHWAY INHIBITOR AND ROCK INHIBITOR

#639
US20240293412A1
Human necessities

NAMPT ACTIVATORS FOR TREATING METABOLIC AND NEUROLOGICAL DISORDERS

#640
US20240293413A1
Human necessities

COMPOUND AND METHOD FOR TREATING CHEMOTHERAPY-RELATED GASTROINTESTINAL SIDE EFFECTS

#641
US20240293414A1
Human necessities

GONADOTROPIN-RELEASING HORMONE ANTAGONIST DOSING REGIMENS FOR THE TREATMENT OF ENDOMETRIOSIS

#642
US20240293415A1
Human necessities

COMBINATION THERAPIES

#643
US20240293416A1
Human necessities

TREATMENT OF LIVER DISORDERS WITH A THR-ß AGONIST

#644
US20240293417A1
Human necessities

MEDICAMENT FOR PREVENTING AND/OR TREATING DRY EYE

#645
US20240293418A1
Human necessities

COMBINATION THERAPY FOR TREATING CANCER

#646
US20240293419A1
Human necessities

COMBINATION THERAPY FOR TREATING CANCER

#647
US20240293420A1
Human necessities

PHARMACEUTICAL COMPOSITION, PREPARATION, AND PREPARATION METHOD THEREFOR AND USE THEREOF

#648
US20240293421A1
Human necessities

CRYSTALLINE COMPOSITION OF TILDACERFONT AND METHODS OF USE AND PREPARATION THEREOF

#649
US20240293422A1
Human necessities

SHP2 AND CDK4/6 INHIBITORS COMBINATION THERAPIES FOR THE TREATMENT OF CANCER

#650
US20240293423A1
Human necessities

STAT DEGRADERS AND USES THEREOF

#651
US20240293424A1
Human necessities

CARNITINE-PALMITOYL-TRANSFERASE-1 (CPT-1) INHIBITORS FOR USE IN A METHOD OF PREVENTING OR TREATING SEPSIS IN A MAMMALIAN SUBJECT

#652
US20240293425A1
Human necessities

BZD-1 AS A CHEMOSENSITIZER OF CANCER

#653
US20240293426A1
Human necessities

INTRAVENOUS ISTAROXIME FOR THE TREATMENT OF ACUTE HEART FAILURE

#654
US20240293427A1
Human necessities

PHARMACEUTICAL KIT FOR PARENTERAL CO-ADMINISTRATION

#655
US20240293428A1
Human necessities

AQUEOUS, ROOM-TEMPERATURE STABLE ROCURONIUM COMPOSITION

#656
US20240293429A1
Human necessities

MICROBIAL-TRIGGERED ORAL INTESTINAL DRUG DELIVERY FORMULATION AND METHOD OF PREPARATION THEREOF

#657
US20240293430A1
Human necessities

WITHAFERIN A AND IMMUNE CHECKPOINT BLOCKER COMBINATION THERAPIES

#658
US20240293431A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT AND/OR PREVENTION OF ALZHEIMER'S DISEASE

#659
US20240293432A1
Human necessities

Use of Cannabidiol to Improve Rehabilitation in Lung Cancer

#660 ✅ Patent 12,318,399 granted on 2025-06-03
US20240293433A1
Human necessities

Stabilized compositions comprising cannabidiol

#661
US20240293434A1
Human necessities

COMBINATION THERAPY EFFECTIVE AGAINST MICROORGANISMS, INCLUDING DRUG RESISTANT MICROORGANISMS

#662
US20240293435A1
Human necessities

Methods and Compositions for Treating Human Disorders Using D-Cycloserine and a Psychedelic Agent

#663
US20240293436A1
Human necessities

Methods Of Treating Fabry Disease In Patients Having A Mutation In The GLA Gene

#664
US20240293437A1
Human necessities

METHODS OF SELECTIVELY MODULATING GASTROINTESTINAL MICROBIAL GROWTH

#665 ✅ Patent 12,268,702 granted on 2025-04-08
US20240293438A1
Human necessities

Antitumor pharmaceutical composition comprising azvudine and chemotherapeutic agent

#666
US20240293439A1
Human necessities

TREATMENT REGIMENS

#667
US20240293440A1
Human necessities

METHOD FOR PREVENTING OR TREATING DENTIN-DENTAL PULP DISEASE OR PERIODONTAL DISEASE, CONTAINING LPAR2 INHIBITOR

#668
US20240293441A1
Human necessities

NEW THERAPEUTIC USE OF TYPE 2 IODOTHYRONINE DEIODINASE (D2) INHIBITORS

#669
US20240293442A1
Human necessities

ASSOCIATION OF MOLECULAR OXYGEN AND HYALURONIC ACID OR ITS SALTS FOR USE IN THE TREATMENT OF SYMPTOMATOLOGY ASSOCIATED WITH VULVAR VESTIBULITIS

#670
US20240293443A1
Human necessities

HEPARAN SULFATE MIMETICS TO IMPROVE GLUCOSE CLEARANCE

#671
US20240293444A1
Human necessities

PHARMACEUTICAL COMPOSITION

#672
US20240293445A1
Human necessities

SYSTEM FOR TRANSPORTING AND DELIVERING OF NITRIC OXIDE

#673
US20240293446A1
Human necessities

TCM THROAT TEA METHOD AND COMPOSITION

#674
US20240293447A1
Human necessities

Materials and Methods for Prevention and Treatment of Diarrhea and Inflammation in the Gastrointestinal Tract

#675
US20240293448A1
Human necessities

COMPOSITION FOR TREATING BONE LOSS

#676
US20240293449A1
Human necessities

COMPOSITION FOR TREATING BONE LOSS

#677
US20240293450A1
Human necessities

COMPOSITION FOR TREATING BONE LOSS

#678
US20240293451A1
Human necessities

ANGIOGENESIS MATERIAL, BONE-REGENERATION-PROMOTING MATERIAL, METHOD FOR PRODUCING ANGIOGENESIS MATERIAL, AND METHOD FOR PRODUCING BONE-REGENERATION-PROMOTING MATERIAL

#679
US20240293452A1
Human necessities

COMPOSITIONS AND METHODS OF ENHANCING ANTI-TUMOR RESPONSE USING HYBRID NEUTROPHILS

#680
US20240293453A1
Human necessities

MATERIALS AND METHODS FOR BINDING SIGLEC-3/CD33

#681
US20240293454A1
Human necessities

TCR-T CELL FOR KILLING TUMORS, AND PREPARATION METHOD THEREFOR AND USE THEREOF

#682
US20240293455A1
Human necessities

ARMED NK CELLS FOR UNIVERSAL CELL THERAPY

#683
US20240293456A1
Human necessities

COMBINATIONS OF SMALL MOLECULE DRUG CONJUGATE AND CAR-EXPRESSING CYTOTOXIC LYMPHOCYTES AND METHODS OF TREATING CANCER USING THE SAME

#684
US20240293457A1
Human necessities

CLAUDIN18.2 CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF

#685
US20240293458A1
Human necessities

3-SUBSTITUTED PIPERIDINE COMPOUNDS FOR CBL-B INHIBITION, AND USE THEREOF

#686
US20240293459A1
Human necessities

PEPTIDES AND ENGINEERED T CELL RECEPTORS TARGETING SARS-COV-2 ANTIGENS AND METHODS OF USE

#687
US20240293460A1
Human necessities

DKK1/HLA-A2 BINDING MOLECULES AND METHODS OF THEIR USE

#688
US20240293461A1
Human necessities

Methods of Treating T Cell Exhaustion by Inhibiting or Modulating T Cell Receptor Signaling

#689
US20240293462A1
Human necessities

Immune Cell Fusion (ICF) and Uses Thereof

#690 ✅ Patent 12,226,435 granted on 2025-02-18
US20240293463A1
Human necessities

Bispecific OR-gate chimeric antigen receptor responsive to CD20 and CD19

#691
US20240293464A1
Human necessities

TISSUE REPAIR

#692
US20240293465A1
Human necessities

Methods for Treating and/or Preventing Graft-Versus-Host Disease and/or Diffuse Alveolar Hemorrhage and/or Veno-Occlusive Disease Associated with Hematopoietic Stem Cell Transplant

#693
US20240293466A1
Human necessities

DIFFERENTIAL CXCR4 EXPRESSION ON HEMATOPOIETIC PROGENITOR CELLS VERSUS STEM CELLS DIRECTS HOMING AND LONG-TERM ENGRAFTMENT

#694
US20240293467A1
Human necessities

DOPAMINERGIC NEURON PROGENITOR CELLS OR CELL DERIVATIVES THEREOF OBTAINED FROM LINEAGE RESTRICTED PLURIPOTENT STEM CELLS

#695
US20240293468A1
Human necessities

FIBROBLAST DELIVERY OF TUMOR INHIBITORY AGENTS

#696
US20240293469A1
Human necessities

FIBROBLAST DELIVERY OF TUMOR INHIBITORY AGENTS

#697
US20240293470A1
Human necessities

EXOSOMES DERIVED FROM IMMORTALIZED MESENCHYMAL STROMAL CELLS (hMSCs) FOR USE AS A MEDICAMENT

#698
US20240293471A1
Human necessities

PLACENTAL CELL TREATMENT FOR CRITICAL LIMB ISCHEMIA PATIENT SUBPOPULATIONS

#699
US20240293472A1
Human necessities

Bee Product Extracts, Methods of Production, and Uses Thereof

#700
US20240293473A1
Human necessities

METHODS FOR DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES

#701
US20240293474A1
Human necessities

Programmable Nanoencapsulation for Delivery of Probiotics in Vivo

#702
US20240293475A1
Human necessities

USE OF AKKERMANSIA IN THE TREATMENT OF ORAL DISEASES

#703
US20240293476A1
Human necessities

Methods and Compositions for Changing Metabolite Levels in a Subject

#704
US20240293477A1
Human necessities

AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF DIAPER RASH, ATHLETE’S FOOT, CONTACT DERMATITIS, PERSPIRATION, AND BODY ODOR

#705
US20240293478A1
Human necessities

IMMUNOSTIMULATORY BACTERIA FOR CONVERTING MACROPHAGES INTO A PHENOTYPE AMENABLE TO TREATMENT, AND COMPANION DIAGNOSTIC FOR IDENTIFYING SUBJECTS FOR TREATMENT

#706
US20240293479A1
Human necessities

PRODUCTION OF A PROBIOTIC COMPOSITION

#707 ✅ Patent 12,350,298 granted on 2025-07-08
US20240293480A1
Human necessities

MICROBIOME RELATED IMMUNOTHERAPIES

#708
US20240293481A1
Human necessities

METHODS AND COMPOSITIONS FOR PREDICTING CANCER SURVIVAL AND CAR T CELL TOXICITY

#709
US20240293482A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING BIOFILMS, INFECTIONS AND PERIODONTITIS

#710
US20240293483A1
Human necessities

PROBIOTIC COMPOSITION FOR THE TREATMENT OF INCREASED INTESTINAL PERMEABILITY

#711
US20240293484A1
Human necessities

LACTOBACILLUS PLANTARUM GB104 STRAIN AND COMPOSITION COMPRISING SAME FOR PREVENTION OR TREATMENT OF CANCER

#712
US20240293485A1
Human necessities

COMPOSITIONS AND METHODS USING A COMBINATION OF AT LEAST ONE FIBER AND AT LEAST ONE PROBIOTIC TO IMPROVE MICROBIOME RESILIENCE

#713
US20240293486A1
Human necessities

Compositions For and Methods of Promoting Respiratory Health

#714
US20240293487A1
Human necessities

IMMUNOEVASIVE ANTI-TUMOR ADENOVIRUS

#715
US20240293488A1
Human necessities

PHYSIOLOGICALLY ACCEPTABLE YEAST COMPOSITIONS AND USES THEREOF

#716
US20240293489A1
Human necessities

PLANT EXTRACTS WITH ANTI-DIABETIC AND OTHER USEFUL ACTIVITIES

#717
US20240293490A1
Human necessities

CHRYSANTHEMUM ZAWADSKII EXTRACT AND PREPARING METHOD THEREOF

#718
US20240293491A1
Human necessities

EFFICIENT LIPID DELIVERY TO HUMAN TEAR FILM USING A SALT-SENSITIVE EMULSION SYSTEM

#719
US20240293492A1
Human necessities

TANNIN-BASED ANTIPROLIFERATIVE PHARMACEUTICAL

#720
US20240293493A1
Human necessities

COMPOSITION FOR ALLEVIATING, TREATING, OR PREVENTING MUSCULAR DISEASES, OR IMPROVING MUSCULAR FUNCTIONS, CONTAINING KOREAN MINT EXTRACT OR TILIANIN AS ACTIVE INGREDIENT

#721
US20240293494A1
Human necessities

COMPOSITION FOR IMPROVING COGNITIVE ABILITY OR MEMORY ABILITY, CONTAINING FERMENTED PERILLA FRUTESCENS EXTRACT, AND USE THEREOF

#722
US20240293495A1
Human necessities

NOVEL THERAPEUTIC COMPOSITION BASED ON ESSENTIAL OILS AT LOW DOSES

#723
US20240293496A1
Human necessities

PROCESS FOR PURIFICATION OF MITRAGYNINE

#724
US20240293497A1
Human necessities

COMPOSITIONS

#725
US20240293498A1
Human necessities

ANTI-CANCER COMPOSITION

#726
US20240293499A1
Human necessities

VISTA AGONISTS AND RELATED COMPOSITIONS AND METHODS

#727
US20240293500A1
Human necessities

PEPTIDE HAVING ANTICANCER ACTIVITY, AND USE THEREOF

#728
US20240293501A1
Human necessities

Reagents, Pharmaceutical Formulations, and Methods for Treating and Preventing Viral Infection

#729
US20240293502A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING TEIXOBACTIN

#730
US20240293503A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING MICROBIAL INFLAMMATION

#731
US20240293504A1
Human necessities

RECOMBINANT POLYPEPTIDES AND COMBINATIONS FOR USE IN THE TREATMENT OF CANCER

#732
US20240293505A1
Human necessities

REVERSAL OF CTL EXHAUSTION WITH ANNEXIN V

#733 ✅ Patent 12,239,686 granted on 2025-03-04
US20240293506A1
Human necessities

Immune checkpoint inhibitor combinations

#734
US20240293507A1
Human necessities

Methods for Enhancing Immune Checkpoint Inhibitor Therapy

#735
US20240293508A1
Human necessities

METHODS OF TREATING METABOLIC DISORDERS ASSOCIATED WITH LIPODYSTROPHIES AND DEFECTS IN INSULIN PRODUCTION OR SIGNALING

#736
US20240293509A1
Human necessities

METHODS OF TREATING INFLAMMATORY BOWEL DISEASE

#737 ✅ Patent 12,201,673 granted on 2025-01-21
US20240293510A1
Human necessities

Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein

#738
US20240293511A1
Human necessities

HEPCIDIN MIMETICS FOR TREATMENT OF HEREDITARY HEMOCHROMATOSIS

#739
US20240293512A1
Human necessities

THERAPEUTIC USE OF COMBINATION INCLUDING TRIPLE AGONIST HAVING ACTIVITIES TO ALL OF GLUCAGON, GLP-1, AND GIP RECEPTORS

#740
US20240293513A1
Human necessities

USE OF MAZDUTIDE

#741
US20240293514A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING GLP-1R AGONISTS

#742
US20240293515A1
Human necessities

STABLE LIQUID FORMULATIONS OF GLUCAGON-LIKE PEPTIDE 1 OR ANALOGUES THEREOF

#743
US20240293516A1
Human necessities

FACTOR IX SUBCUTANEOUS ADMINISTRATION WITH ENHANCED SAFETY

#744 ✅ Patent 12,226,461 granted on 2025-02-18
US20240293517A1
Human necessities

Chimeric endolysin polypeptide, cluster 3b

#745
US20240293518A1
Human necessities

METHOD FOR PROPHYLAXIS AND/OR TREATMENT OF ErbB2 POSITIVE CANCERS

#746
US20240293519A1
Human necessities

Universal mRNA Vaccine to Treat Dementia-Causing Neurodegenerative Disorders

#747
US20240293520A1
Human necessities

Antigenic Peptides For Prevention And Treatment Of Cancer

#748
US20240293521A1
Human necessities

COMBINATION USE OF WT1 ANTIGEN PEPTIDE AND IMMUNOMODULATOR

#749 ✅ Patent 12,168,048 granted on 2024-12-17
US20240293522A1
Human necessities

Bacillus Calmette-Guerin (BCG) and antigen presenting cells for treatment of bladder cancer

#750
US20240293523A1
Human necessities

VACCINE METHOD AND COMPOSITION FOR BACTERIAL DISEASES IN INVERTEBRATES

#751
US20240293524A1
Human necessities

MULTIPLE FUNCTIONALIZED noMV CONJUGATES

#752
US20240293525A1
Human necessities

VACCINE AGAINST AFRICAN SWINE FEVER VIRUS INFECTION

#753
US20240293526A1
Human necessities

EBOLAVIRUS AND MARBURGVIRUS VACCINES

#754
US20240293527A1
Human necessities

DEOPTIMIZED YELLOW FEVER VIRUS AND METHODS AND USES THEREOF

#755
US20240293528A1
Human necessities

METHODS OF TREATMENT OF HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESION (HSIL)

#756
US20240293529A1
Human necessities

IMMUNOGENIC COMPOSITIONS AND USES THEREOF

#757
US20240293530A1
Human necessities

MULTIVALENT INFLUENZA NANOPARTICLE VACCINES

#758
US20240293531A1
Human necessities

INACTIVATED SARS-COV-2 VIRUS VACCINE

#759
US20240293532A1
Human necessities

REPLICATION-COMPETENT ADENOVIRUS TYPE 4 SARS-COV-2 VACCINES AND THEIR USE

#760
US20240293533A1
Human necessities

RECOMBINANT MEASLES VIRUS

#761
US20240293534A1
Human necessities

CORONAVIRUS GLYCOSYLATION VARIANT VACCINES

#762
US20240293535A1
Human necessities

Therapeutic Viral Vaccine

#763
US20240293536A1
Human necessities

PORCINE BIVALENT SUBUNIT VACCINE COMPOSITION IN A SINGLE DOSE

#764
US20240293537A1
Human necessities

AMPHIPHILIC IMIQUIMOD-GRAFTED LAURYL GAMMA-POLYGLUTAMATE AND USE THEREOF

#765
US20240293538A1
Human necessities

NOVEL METHODS FOR MANUFACTURING AN ADJUVANT

#766
US20240293539A1
Human necessities

BOVINE COLOSTRUM DERIVED ANTIBODIES AND USES THEREOF

#767
US20240293540A1
Human necessities

COMPOSITIONS AND METHODS FOR INCREASING THE SERUM HALF-LIFE OF A THERAPEUTIC AGENT TARGETING COMPLEMENT C5

#768
US20240293541A1
Human necessities

LSP1-DEFICIENT T CELL

#769
US20240293542A1
Human necessities

PHARMACEUTICAL COMPOSITION CONTAINING REGULATORY T CELLS AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASES

#770
US20240293543A1
Human necessities

ENGINEERED CELLS FOR THERAPY

#771
US20240293544A1
Human necessities

MESOTHELIN ISOFORM BINDING MOLECULES AND CHIMERIC PD1 RECEPTOR MOLECULES, CELLS CONTAINING THE SAME AND USES THEREOF

#772
US20240293545A1
Human necessities

Genetically Engineered Phagocytes, and Related Compositions, Vectors, Methods and Systems

#773
US20240293546A1
Human necessities

D2C7 EGFR AND EGFR VIII BI-SPECIFIC CHIMERIC ANTIGEN RECEPTOR CONSTRUCTS AND METHODS OF MAKING AND USING SAME

#774
US20240293547A1
Human necessities

POLYMERIC PERFLUOROCARBON NANOEMULSIONS FOR ULTRASONIC DRUG UNCAGING

#775
US20240293548A1
Human necessities

CONTACT LENS FOR PHOTODYNAMIC INACTIVATION OF GERMS, PRODUCT AND METHOD OF TREATING FUNGAL KERATITIS BY APPLYING THE SAME

#776
US20240293549A1
Human necessities

Conjugates And Conjugating Reagents

#777
US20240293550A1
Human necessities

BRANCHED OLIGONUCLEOTIDES

#778
US20240293551A1
Human necessities

USE OF ST-TYPE LIPID COMPOUNDS IN PREPARATION OF NUCLEIC ACID DELIVERY REAGENT AND RELATED PRODUCT

#779 ✅ Patent 12,233,112 granted on 2025-02-25
US20240293552A1
Human necessities

Compositions comprising pharmaceutically acceptable salts of amylin analogs and uses thereof

#780
US20240293553A1
Human necessities

P-SELECTIN INHIBITORS AND USES THEREOF

#781
US20240293554A1
Human necessities

QUATERNIZED NICOTINAMIDE ADENINE DINUCLEOTIDE SALVAGE PATHWAY INHIBITOR CONJUGATES

#782
US20240293555A1
Human necessities

CARBOHYDRATE CONJUGATES FOR THE DELIVERY OF THERAPEUTIC OLIGONUCLEOTIDES

#783
US20240293556A1
Human necessities

CARBOHYDRATE DERIVATIVES AND KITS FOR CELL SURFACE LABELING

#784
US20240293557A1
Human necessities

PROTEOLYSIS TARGETING CHIMERAS AND METHODS OF USE THEREOF

#785
US20240293558A1
Human necessities

KRAS INHIBITOR CONJUGATES

#786
US20240293559A1
Human necessities

SHP2 inhibitor, pharmaceutical composition containing the same and application thereof

#787
US20240293560A1
Human necessities

POLYOXAZOLINE-DRUG CONJUGATES WITH NOVEL PHARMACOKINETIC PROPERTIES

#788
US20240293561A1
Human necessities

BRAIN PERMEABLE MULTIFUNCTIONAL SYSTEM AND USES THEREOF

#789
US20240293562A1
Human necessities

METHODS FOR USING NEUROTROPHIN RECEPTOR BINDING CONJUGATE COMPOSITIONS IN THE TREATMENT OF A NEUROLOGICAL CONDITION

#790
US20240293563A1
Human necessities

GLP-1 RECEPTOR LIGAND MOIETY CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF

#791
US20240293564A1
Human necessities

LOCALIZED DELIVERY OF ANTI-FUGETACTIC AGENT FOR TREATMENT OF CANCER

#792
US20240293565A1
Human necessities

ANTI-HER3 ANTIBODY, ANTIBODY DRUG CONJUGATE CONTAINING THE SAME, AND USE THEREOF

#793
US20240293566A1
Human necessities

ANTI-EGFRvIII ANTIBODY DRUG CONJUGATES AND USES THEREOF

#794
US20240293567A1
Human necessities

NOVEL CYCLIC DINUCLEOTIDE DERIVATIVE AND ANTIBODY-DRUG CONJUGATE THEREOF

#795 ✅ Patent 12,263,225 granted on 2025-04-01
US20240293568A1
Human necessities

Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of use thereof to target dystrophin and to treat Duchenne muscular dystrophy

#796
US20240293569A1
Human necessities

LINKER FOR ANTIBODY-DRUG CONJUGATE

#797
US20240293570A1
Human necessities

HIGHLY STABLE TARGETED LINKER-DRUG CONJUGATE

#798
US20240293571A1
Human necessities

BRAIN-TARGETED ANTIBODY NANOPARTICLE FOR NEURODEGENERATIVE DISEASES THERAPY

#799
US20240293572A1
Human necessities

THERAPEUTIC-AGENT-RELEASING HYDROGELS AND PRECURSORS THEREOF

#800
US20240293573A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, CONTAINING LIPID-PHOTOTHERMAL NANOPARTICLE HAVING ANTIBODY BOUND TO SURFACE

#801
US20240293574A1
Human necessities

CATIONIC LIPIDS AND COMPOSITIONS THEREOF

#802
US20240293575A1
Human necessities

NANOPARTICLES COMPRISING PEPTIDES INCLUDING AN N-TERMINAL LINKER

#803
US20240293576A1
Human necessities

NUCLEIC ACID CONSTRUCT FOR AIDS GENE THERAPY

#804
US20240293577A1
Human necessities

METHODS AND MEANS FOR THE PREVENTION AND/OR TREATMENT OF HEMOPHILIC ARTHROPATHY IN HEMOPHILIA

#805
US20240293578A1
Human necessities

METHODS OF TREATING MITOCHONDRIAL DISORDERS

#806
US20240293579A1
Human necessities

Composition Comprising Trim31 and Rhbdf2 for Treatment of NAFLD/NASH

#807
US20240293580A1
Human necessities

Optimized RPE65 Promoter and Coding Sequences

#808
US20240293581A1
Human necessities

NEUROPROTECTION GENE THERAPY

#809
US20240293582A1
Human necessities

DNA COMPOSITIONS COMPRISING MODIFIED CYTOSINE

#810
US20240293583A1
Human necessities

RADIOPAQUE CROSSLINKED ACRYLAMIDE COPOLYMERS AND USES THEREOF

#811 ✅ Patent 12,115,233 granted on 2024-10-15
US20240293584A1
Human necessities

Imaging and radiotherapeutics agents targeting fibroblast-activation protein-α (FAP-α)

#812
US20240293585A1
Human necessities

HIGH MOLECULAR WEIGHT ZWITTERION-CONTAINING POLYMERS

#813
US20240293586A1
Human necessities

RADIOLABELED COMPOUND AND USE THEREOF

#814
US20240293587A1
Human necessities

CXCR4-TARGETED DIAGNOSTIC AND THERAPEUTIC AGENTS WITH REDUCED SPECIES SELECTIVITY

#815
US20240293588A1
Human necessities

THERAPEUTIC CONJUGATES

#816
US20240293589A1
Human necessities

HYPOCHLOROUS ACID ULTRASOUND PROBE DISINFECTION CHAMBER

#817
US20240293590A1
Human necessities

Sanitizing Appliance

#818
US20240293591A1
Human necessities

ULTRAVIOLET DISINFECTING APPARATUS

#819
US20240293592A1
Human necessities

System And Method For Automating Verification Of Medical Instrument Sterilization Compatibility And Sterilization Cycle Selection

#820
US20240293593A1
Human necessities

AIR SANITATION DEVICE BY EMISSION OF A BARRIER OF ULTRAVIOLET RADIATION IN AN AIR FLOW

#821
US20240293594A1
Human necessities

HEMOSTATIC SPONGE

#822
US20240293595A1
Human necessities

MULTILAYER DEVICE FOR SUPPLYING NITRIC OXIDE

#823
US20240293596A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING WOUNDS

#824
US20240293597A1
Human necessities

SILVER NANOPLATE COMPOSITIONS AND METHODS

#825
US20240293598A1
Human necessities

Shape memory material with chelating system and preparation method thereof

#826
US20240293599A1
Human necessities

BONE-REGENERATION-PROMOTING MATERIAL, AND METHOD FOR PRODUCING BONE-REGENERATION-PROMOTING MATERIAL

#827
US20240293600A1
Human necessities

COMPOSITIONS, METHODS, AND DEVICES FOR SUSTAINED RELEASE OF AN AGENT

#828
US20240293601A1
Human necessities

SKELETAL STRUCTURE FOR ARTIFICIAL PINNA AND ARTIFICIAL CARTILAGINOUS TISSUE, AND ARTIFICIAL PINNA USING SAME

#829
US20240293602A1
Human necessities

DIAPHRAGM FOR A BREAST PUMP AND A BREAST PUMP HAVING THE DIAPHRAGM

#830
US20240293603A1
Human necessities

Intelligent Adjustment of Computing Device Operations

#831
US20240293604A1
Human necessities

SYSTEM AND METHOD FOR COLLECTING PLASMA

#832
US20240293605A1
Human necessities

Device for Removal of Implants and Associated Method of Use

#833
US20240293606A1
Human necessities

SYSTEM AND METHOD FOR TREATING A GASTROINTESTINAL TRACT OF A SUBJECT

#834
US20240293607A1
Human necessities

NEGATIVE PRESSURE WOUND THERAPY DEVICES

#835
US20240293608A1
Human necessities

ELECTRONIC AUTOMATICALLY ADJUSTING BIDET COMMODE WITH ARTIFICIAL INTELLIGENCE AND SPECTROSCOPY SOFTWARE

#836
US20240293609A1
Human necessities

LATCH FOR CAPTURING AND SECURING A CASSETTE TO A MEDICAL DEVICE

#837
US20240293610A1
Human necessities

SYSTEM AND METHOD OF MONITORING AND MANAGING A REMOTE INFUSION REGIMEN

#838
US20240293611A1
Human necessities

A SYSTEM FOR THE CONTROLLED ADMINISTRATION OF A SUBSTANCE WITH AN IMPLANTABLE INFUSION DEVICE PROVIDED WITH AN IMPROVED DOCKING GROUP FOR RELIABLY DOCKING AN INGESTIBLE SUBSTANCE CARRIER

#839
US20240293612A1
Human necessities

DRUG DELIVERY DEVICE

#840
US20240293613A1
Human necessities

PIEZO-ACTUATED DRIVE UNIT FOR SYRINGE PUMP

#841
US20240293614A1
Human necessities

AGENT ADMINISTERING MEDICAL DEVICE

#842
US20240293615A1
Human necessities

INFUSION SET AND INSERTER ASSEMBLY SYSTEMS AND METHODS

#843
US20240293616A1
Human necessities

LIQUID MEDICINE INJECTION DEVICE

#844 ✅ Patent 12,257,420 granted on 2025-03-25
US20240293617A1
Human necessities

Initial total daily insulin setting for user onboarding

#845
US20240293618A1
Human necessities

DETERMINATION OF DOSES OF INSULIN AND RELATED SYSTEMS, METHODS, AND DEVICES

#846
US20240293619A1
Human necessities

METHOD TO IMPROVE SAFETY MONITORING IN TYPE-1 DIABETIC PATIENTS BY DETECTING IN REAL-TIME FAILURES OF THE GLUCOSE

#847
US20240293620A1
Human necessities

ARTICLES, SYSTEMS, AND METHODS FOR THE INJECTION OF VISCOUS FLUIDS

#848
US20240293621A1
Human necessities

Autoinjector

#849
US20240293622A1
Human necessities

Autoinjector

#850
US20240293623A1
Human necessities

ASSEMBLABLE COMPACT SYRINGE WITH SIDE MOUNTED PLUNGER ROD

#851
US20240293624A1
Human necessities

INSULIN INJECTION ASSISTANCE SYSTEMS, METHODS, AND DEVICES

#852
US20240293625A1
Human necessities

Data Logging Device for Monitoring Use of an Injection Device

#853
US20240293626A1
Human necessities

Safety Clip for Medical Injection Device

#854
US20240293627A1
Human necessities

SYSTEMS AND METHODS FOR MIXING SYRINGE VALVE ASSEMBLIES

#855
US20240293628A1
Human necessities

SPRAY DEVICE AND AIR TREATMENT DEVICE

#856
US20240293629A1
Human necessities

VAPORIZER CARTRIDGE AND INHALER COMPRISING SUCH A VAPORIZER CARTRIDGE

#857
US20240293630A1
Human necessities

MULTIFUNCTIONAL WEARING DEVICE

#858
US20240293631A1
Human necessities

CLOSED INTUBATION SYSTEMS HAVING IMPROVED AIRWAY ACCESS FOR EXAMINATION DEVICES

#859
US20240293632A1
Human necessities

TRACHEAL TUBE ASSEMBLY

#860
US20240293633A1
Human necessities

LARYNGEAL TUBE

#861 ✅ Patent 12,214,130 granted on 2025-02-04
US20240293634A1
Human necessities

Systems and methods for assisting patient airway management

#862
US20240293635A1
Human necessities

RESPIRATORY INTERFACE ASSEMBLY

#863
US20240293636A1
Human necessities

IMPROVED BYPASS CONDUIT HAVING A PORT

#864
US20240293637A1
Human necessities

ANESTHESIA MACHINE, RESPIRATORY SUPPORT DEVICE, AND VENTILATION CONTROL METHOD

#865
US20240293638A1
Human necessities

HEATING ARRANGEMENTS FOR HUMIDIFICATION SYSTEMS

#866
US20240293639A1
Human necessities

TUB FOR HUMIDIFIER

#867
US20240293640A1
Human necessities

SYSTEM AND METHOD FOR SOOTHING INFANTS

#868
US20240293641A1
Human necessities

CATHETER AND METHOD FOR PREPARING CATHETER TRANSITION STRUCTURE

#869
US20240293642A1
Human necessities

GUIDE EXTENSION CATHETER

#870
US20240293643A1
Human necessities

Devices and Methods for Fluid Transfer Through a Placed Peripheral Intravenous Catheter

#871
US20240293644A1
Human necessities

SUBCUTANEOUS TUNNELING CATHETER FOR PERITONEAL ACCESS

#872
US20240293645A1
Human necessities

MULTI-LUMEN CENTRAL LINE

#873
US20240293646A1
Human necessities

SAFETY CATHETER ASSEMBLY

#874
US20240293647A1
Human necessities

ANGIOPLASTY DEVICE

#875
US20240293648A1
Human necessities

PARANASAL SINUS FLUID ACCESS IMPLANTATION TOOLS, ASSEMBLIES, KITS AND METHODS

#876
US20240293649A1
Human necessities

SYSTEMS, CATHETERS, AND METHODS FOR TREATING ALONG THE CENTRAL NERVOUS SYSTEM

#877 ✅ Patent 12,285,581 granted on 2025-04-29
US20240293650A1
Human necessities

Drug delivery device and methods for using same

#878
US20240293651A1
Human necessities

CAPSULE ADMINISTERING ASSEMBLY

#879
US20240293652A1
Human necessities

Systems, Devices and Methods for Intradermal or Subdermal Fluid Delivery

#880 ✅ Patent 12,311,137 granted on 2025-05-27
US20240293653A1
Human necessities

Hydrogel microneedle patch based on three-dimensional framework structure, and preparation method and application thereof

#881
US20240293654A1
Human necessities

Port with Detachable Stem

#882
US20240293655A1
Human necessities

TOOLS AND METHODS FOR DIRECTLY ACCESSING THE CAROTID ARTERY

#883
US20240293656A1
Human necessities

FUNCTIONAL ADAPTER FOR DIALYSIS MACHINE

#884
US20240293657A1
Human necessities

MEDICAL CONNECTOR

#885
US20240293658A1
Human necessities

INTRAVENOUS PRIMING CAP

#886
US20240293659A1
Human necessities

Pinch Clamp Devices, Methods, and Systems

#887 ✅ Patent 12,329,958 granted on 2025-06-17
US20240293660A1
Human necessities

BLOOD PUMP

#888
US20240293661A1
Human necessities

INTRAVASCULAR BLOOD PUMP

#889 ✅ Patent 12,257,427 granted on 2025-03-25
US20240293662A1
Human necessities

Implantable heart pump systems including an improved apical connector and/or graft connector

#890
US20240293663A1
Human necessities

THERAPEUTIC ELECTRICAL MUSCLE STIMULATION APPARATUS AND METHOD OF IMPROVING MEDICAL PROCEDURE OUTCOMES

#891
US20240293664A1
Human necessities

THERAPEUTIC ELECTRICAL MUSCLE STIMULATION APPARATUS AND METHOD OF TREATMENT

#892
US20240293665A1
Human necessities

ELICITING SWALLOWING USING ELECTRICAL STIMULATION APPLIED VIA SURFACE ELECTRODES

#893
US20240293666A1
Human necessities

SYSTEMS AND METHODS FOR MANAGED TRAINING AND REHABILITATION VIA ELECTRICAL STIMULATION

#894
US20240293667A1
Human necessities

Current Generation Architecture for an Implantable Medical Device

#895
US20240293668A1
Human necessities

MONOLITHIC PERICARDIAL PACEMAKERS

#896
US20240293669A1
Human necessities

Wrist-Worn Independent 3-Point Acupuncture Stimulator

#897
US20240293670A1
Human necessities

Wrist-Worn Independent 3-Point Acupuncture Stimulator

#898
US20240293671A1
Human necessities

TREATMENT OF OVERACTIVE BLADDER WITH PHASE-CONTINGENT PUDENDAL NERVE STIMULATION

#899 ✅ Patent 12,311,173 granted on 2025-05-27
US20240293672A1
Human necessities

Modular implant delivery and positioning system

#900
US20240293673A1
Human necessities

NEUROSTIMULATOR TO AID IN RECOVERY FROM STROKE OR OTHER LIMITATIONS IN HUMAN FUNCTION